Diabetes Core Update

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Management and Outcomes of Severe Hypoglycemia Treated by Emergency Medical Services in the U.S. Upper Midwest T2DM Diabetes Microvascular Disease Diagnosis and Treatment After High-Deductible Health Plan Enrollment Historic Residential Redlining and Present-day Diabetes Mortality and Years of Life Lost: The Persistence of Structural Racism Model for Integrati

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Heart Failure: An Underappreciated Complication of Diabetes. A Consensus Report of the American Diabetes Association T2DM Early and ongoing stable glycaemic control is associated with a reduction in major adverse cardiovascular events in people with type 2 diabetes Effect of Deintensifying Diabetes Medications on Negative Events in Older Veteran Nursing Home R

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Risks and burdens of incident diabetes after Covid-19 Trends in Timing of and Glycemia at Initiation of Second-line treatment for T2DM Safety of Empagliflozin in Patients with Type 2 Diabetes and CKD Weight Change During Postintervention Follow-up of the Look AHEAD Study Progression to Diabetes Among Older Adults With Prediabetes Association between DM and g

In this special three-part series we will be doing a deep dive into diabetic peripheral neuropathy.    In this third episode Drs. J. Robinson Singleton and Robin Marcus join our host, Dr. Neil Skolnik to discuss non-pharmacologic treatment of diabetic peripheral neuropathy.  In part 1 we covered the epidemiology, pathophysiology, clinical manifestations, screening and diagnosis of diabetic peripheral neuropathy and in part 2 of the series we covered pharmacologic management.   This series is supported by an unrestricted educational grant to the American Diabetes Association from Nevro, Inc. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Dr. J. Robinson Singleton and Dr. Robin Marcus. Dr. Singleton is Professor and Vice Chair for VA affairs, Neurology, Director, CTSI Clinical Trials Services Foundation at the University of Utah and Ch

In this special episode on continuous glucose monitoring (CGM) and time in range Dr. Halis Kaan Akturk joins our host, Dr. Neil Skolnik to new technology for CGM and its promises for people with diabetes.  This special episode is supported by an independent educational grant from Abbot. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Dr. Halis Kaan Akturk.  Dr.Akturk is an Assistant Professor of Medicine and Pediatrics at the University of Colorado, Barbara Davis Center for Diabetes and the Communications Director of American Diabetes Association, Diabetes Technology Interest Group. For more information about CGM and Time in Range, please go to: www.professional.diabetes.org/timeinrange  

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: The Incidence of Diabetes Among 2,777,768 Veterans With and Without Recent SARS-CoV-2 Infection Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes Persistence of Risk for Type 2 Diabetes After Gestational Diabetes Finerenone in Patients With Chronic Kidney Disea

In this special three-part series we will be doing a deep dive into diabetic peripheral neuropathy.    In this second episode Dr. Rodica Pop-Busui joins our host, Dr. Neil Skolnik to discuss pharmacologic treatment of diabetic peripheral neuropathy.  In part 1 we covered the epidemiology, pathophysiology, clinical manifestations, screening and diagnosis of diabetic peripheral neuropathy and in part 3 of the series we will cover non-pharmacologic management.   This series is supported by an unrestricted educational grant to the American Diabetes Association from Nevro, Inc. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Dr. Rodica Pop-Busui MD, PhD. Dr. Pop-Busui is the Larry D. Soderquist Professor in Diabetes, Professor of Internal Medicine Metabolism, Endocrinology and Diabetes, Vice Chair of Clinical Research, Department of Intern

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: The carbohydrate-insulin model Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes Type 2 diabetes, glycemic control and its association with dementia and its major sub types Real-world evidence of efficacy and safety of SGLT-2 inhibitors as adjunctive therapy in adults with type

In this special episode on continuous glucose monitoring (CGM) and time in range Dr. Dr. Nicole Ehrhardt joins our host, Dr. Neil Skolnik to discuss potential benefits of CGM use and time in range prior to and during pregnancy for women who have diabetes.     Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Nicole Ehrhardt, M.D., Assistant Professor in the Department of Medicine, Division of Endocrinology and Nutrition, University of Washington. For more information about CGM and Time in Range, please go to: www.professional.diabetes.org/timeinrange    

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-Term Results Universal Subsidized Continuous Glucose Monitoring Funding for Young People With Type 1 Diabetes: Uptake and Outcomes Over 2 Years Dietary Insulinemic Potential and Risk of Total and Cause-Specific Mortality 2022 National Standards for Diabetes Self-

In this special three-part series we will be doing a deep dive into diabetic peripheral neuropathy.    In this first episode Dr. Rodica Pop-Busui joins our host, Dr. Neil Skolnik to discuss the epidemiology, pathophysiology, clinical manifestations, screening and diagnosis of diabetic peripheral neuropathy.  In part 2 we will cover pharmacologic treatment and in part 3 of the series we will cover non-pharmacologic management.   This series is supported by an unrestricted educational grant to the American Diabetes Association from Nevro, Inc. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Dr. Rodica Pop-Busui MD, PhD. Dr. Pop-Busui is the Larry D. Soderquist Professor in Diabetes, Professor of Internal Medicine Metabolism, Endocrinology and Diabetes, Vice Chair of Clinical Research, Department of Internal Medicine, Director, Clinical

In this special episode on continuous glucose monitoring (CGM) and time in range Dr. Wettergreen joins our host, Dr. Neil Skolnik to discuss how to simplify and integrate CGM and time in range into primary care office practices.    This special episode is supported by an independent educational grant from Abbot. Presented by: Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Sara Wettergreen, PharmD, BCACP,  Dr. Wettergreen is an Assistant Professor in the Department of Clinical Pharmacy at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and is a clinical pharmacist at UCHealth Lone Tree Primary Care. For more information about CGM and Time in Range, please go to: www.professional.diabetes.org/timeinrange  

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Remission of Type 2 Diabetes Following a Short-term Intensive Intervention With Insulin Glargine, Sitagliptin, and Metformin Gestational Diabetes Mellitus and the Risks of Overall and Type-Specific Cardiovascular Diseases Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease Changes in the Prevalence of Symptoms of Depression, Loneliness, and Inso

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: The Effect of Discontinuing CGM in Adults With Type 2 Diabetes Treated With Basal Insulin Long-Term Occupational Consequences for Families of Children With Type 1 Diabetes: The Mothers Take the Burden Effect of Metformin and Lifestyle Interventions on Mortality in the Diabetes Prevention Program and Diabetes Prevention Program Association of Sodium-Glucose Cot

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes Kidney outcomes associated with SGLT2 inhibitors versus other glucose-lowering drugs in real-world clinical practice A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes Empagliflozin in Heart Failure with a Preserved Ejection Fraction Patient

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Replacement of Sedentary Behavior by Physical Activities and Structured Exercises and Incident Type 2 Diabetes Glucose Regulation Beyond HbA1c in Type 2 Diabetes Treated With Insulin Chronic Prescribing Trends of Antidiabetes Medications in Patients With Type 2 Diabetes and Diabetic Kidney Disease Type 2 Diabetes Legacy Effect Nationwide Trends in Cardiac Risk

In this special episode on SGLT-2 inhibitors and CKD Drs. John Russell and Neil Skolnik discuss the effects of the SGLT-2 inhibitors in decreasing progression of chronic kidney disease.    This special episide is supported by independent educational grant from AstraZeneca. For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org. Background, Epidemiology, and Pathophysiology of Diabetic Kidney Disease ADA Recommendations for Screening and Diagnosis of Diabetic Kidney Disease ADA Recommendations for Treatment of CKD in Persons with Diabetes Review of the Literature SGLT-2 inhibitor effects on CV and Kidney Outcomes in Patients with T2DM Dapagliflozin in Patients with Chronic Kidney Disease CKD Testing in Patients with T2DM Second-Line Therapy for T2DM Management: The Treatment/Benefit Paradox of CV and Kidney Comorbidities eGFR dip After Starting SGLT-2 inhibitors Dapagliflozin in patients with T2DM and Stages 3b–4 chronic kidney disease Presented by

Diabetes Core Update – September 2021 Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes Chronic Kidney Disease Testing Among Primary Care Patients With Type 2 Diabetes Across 24 U.S. Health Care Organizations Nutritional basis of type 2 diabetes remission Chronic Kidney Disease Testing Among At-Risk Adults in the U.S. Remains Low: Rea

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals. Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting. This issue will review: High out-of-pocket health care cost burden among Medicare beneficiaries with diabetes, 1999-2017 Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin-Treated Diabe